NEW YORK (GenomeWeb News) – Life Technologies today reported that its third-quarter revenues increased 3 percent, or 5 percent on an organic basis, while its net income also climbed higher.

The firm's results, which were driven by sales of products in its Molecular Biology Systems and Genetic Systems divisions, beat analysts' consensus estimates on both the top and bottom line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.